# OnCo record neok-bio (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/neok-bio/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "neok-bio" ;
  schema:name "NEOK Bio"@en ;
  schema:description "NEOK Bio makes antibody-drug conjugates that recognise two proteins on a cancer cell at once before delivering a cell-killing drug, an approach meant to aim the drug more precisely at tumours. Its first two medicines began early human trials in solid tumours in 2026."@en ;
  schema:url <https://onco.cc/companies/neok-bio/>, <https://www.neokbio.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.neokbio.com/>, <https://www.neokbio.com/news-2025-nov04>, <https://www.neokbio.com/neok-bio-initiates-phase1-clinical-trials-of-both-lead-bispecific-adcs>, <https://www.biopharmadive.com/news/neok-bio-bispecific-adc-biotech-startup-launch-abl/804378/> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/adcs/> ;
  onco:technologies <https://onco.cc/technologies/bispecific-adc/>, <https://onco.cc/technologies/adc/> ;
  onco:targets <https://onco.cc/targets/b7h3/>, <https://onco.cc/targets/ror1/>, <https://onco.cc/targets/egfr/> .